OPTImal Management of Antithrombotic Agents: OPTIMA-2 Trial

NCT01955200 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1724

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: Clopidogrel
DRUG: Cilostazol
DRUG: Ticagrelor
DRUG: Clopidogrel
DRUG: Clopidogrel

Sponsor

The First Affiliated Hospital with Nanjing Medical University

Collaborators

[object Object]